第一章：从死神手中夺回生命——药物发现的故事 | Chapter 1: Rescuing Lives from Death—The Tale of Drug Discovery

第一章：从死神手中夺回生命——药物发现的故事

Chapter 1: Rescuing Lives from Death—The Tale of Drug Discovery

---

那是一个寻常的秋日午后，阳光透过波士顿麻省总医院血液科诊室的落地窗，在浅灰色的地板上投下温暖的光斑。萨拉·陈坐在诊室外的候诊椅上，手里攥着那份刚刚拿到手的检查报告，指节因为用力而微微发白。她今年三十四岁，是两个孩子的母亲——七岁的艾米丽和四岁的内森——就在三个月前，她还被同事们称为“永远精力充沛的萨拉”，那个永远能在公司加班到深夜、周末还能组织全家去郊游的职场精英。

Now it was an ordinary autumn afternoon, sunlight streaming through the floor-to-ceiling windows of the hematology department at Massachusetts General Hospital, casting warm patches of light on the light gray floor. Sarah Chen sat in the waiting area outside the examination room, clutching the test report she had just received, her knuckles turning white from the grip. She was thirty-four years old, a mother of two—seven-year-old Emily and four-year-old Nathan. Just three months ago, her colleagues still called her "the perpetually energetic Sarah," the workplace elite who could pull all-nighters at the office and still organize weekend family outings.

然而，命运在她三十四岁生日后的第三天投下了一颗重磅炸弹。那天，她发现自己的锁骨下方出现了一个不痛不痒的肿块——起初她以为只是淋巴结发炎，也许是因为前一周那次感冒还没完全好。但当肿块在一周内从鸽蛋大小长到网球那么大时，她终于预约了医生。活检结果像一把锋利的手术刀，精准地切断了她对未来的所有憧憬：急性淋巴细胞白血病，简称ALL，融合基因检查显示为费城染色体阳性——这是一种恶性程度极高、预后极差的白血病类型。

However, fate dropped a bombshell on her just three days after her thirty-fourth birthday. That day, she discovered a painless lump below her collarbone—at first she thought it was just swollen lymph nodes, perhaps from the cold she hadn't quite recovered from the previous week. But when the lump grew from the size of a pigeon egg to that of a tennis ball within a week, she finally made a doctor's appointment. The biopsy results were like a sharp scalpel, precisely cutting through all her hopes for the future: Acute Lymphoblastic Leukemia, ALL for short, with the Philadelphia chromosome positive—among the most aggressive and poorest-prognosis types of leukemia.

接下来的日子如同坠入了一场永无止境的噩梦。传统的化疗方案在她身上几乎看不到效果，白细胞计数在短暂下降后又开始疯狂反弹。肿瘤科主任罗伯特·张医生坐在她病床边的椅子上，声音低沉而诚恳：“陈女士，我必须对您坦诚。以您目前的情况，常规治疗手段已经很难控制病情了。”他顿了顿，似乎在斟酌接下来的措辞，“但我们正在开展一项新的临床试验，针对像您这样的费城染色体阳性ALL患者。这是一种靶向药物，理论上可以精准地攻击导致您癌症的异常基因。但我必须提醒您，临床试验存在不确定性，也可能没有效果，甚至可能有我们尚未预料到的副作用。”

The days that followed plunged her into an endless nightmare. Traditional chemotherapy showed almost no effect on her body; the white blood cell count would briefly drop before surging again. Dr. Robert Zhang, director of oncology, sat beside her hospital bed, his voice low and sincere: "Ms. Chen, I must be frank with you. With your current condition, conventional treatment methods can barely control the disease." He paused, as if considering his next words, "But we're conducting a new clinical trial for patients like you with Philadelphia chromosome-positive ALL. It's a targeted therapy that can theoretically precisely attack the abnormal genes causing your cancer. But I must warn you—there are uncertainties in clinical trials. It may not work, or there could be side effects we haven't anticipated."

萨拉望向窗外，秋日的阳光依然明媚，远处查尔斯河的水面闪烁着粼粼波光。她想起了孩子们——艾米丽最近正在学钢琴，每次弹奏《致爱丽丝》时都会认真地说“妈妈，这是贝多芬写给你的歌”；内森则是个小话痨，每天从幼儿园回来都会叽叽喳喳地讲述他今天又交到了哪个新朋友。而现在，死亡的阴影正一步步逼近她的孩子、她的家庭。

Sarah gazed out the window; the autumn sun was still bright, and the waters of the distant Charles River sparkled. She thought of her children—Emily had recently started learning piano, and every time she played "Für Elise," she would seriously say, "Mommy, this is Beethoven's song for you." Nathan was a little chatterbox, always babbling about which new friends he'd made at kindergarten. Now, the shadow of death was approaching her children and her family, step by step.

“张医生，”她转回头，目光坚定，“我想参加这个试验。”

"Dr. Zhang," she turned back, her gaze firm, "I want to join the trial."

临床试验的转折点

The Turning Point: Clinical Trials

萨拉参加的这项临床试验，测试的是一种名为达沙替尼（Dasatinib）的新型靶向药物。这是一种酪氨酸激酶抑制剂（Tyrosine Kinase Inhibitor, TKI），它的作用原理可以用一个形象的比喻来解释：如果把癌细胞比作一个失控的疯狂工厂，那么酪氨酸激酶就是驱动这个工厂运转的“电力开关”。正常情况下，这些“开关”会根据身体的需要精密调控细胞的生长和分裂；但在某些癌细胞中，这些“开关”发生了突变，始终处于“打开”的状态，导致细胞无限增殖。达沙替尼的作用，就是精准地关闭这些异常的“电力开关”，从而让癌细胞失去疯狂生长的动力。

The clinical trial Sarah joined tested a new targeted drug called Dasatinib. This was a Tyrosine Kinase Inhibitor (TKI)—its mechanism can be explained with a vivid analogy: if cancer cells are like an out-of-control mad factory, then tyrosine kinases are the "power switches" driving this factory's operation. Normally, these "switches" precisely regulate cell growth and division according to the body's needs. But in certain cancer cells, these "switches" have mutated, remaining permanently "on," causing unlimited cell proliferation. Dasatinib's role is to precisely turn off these abnormal "power switches," starving cancer cells of their manic growth momentum.

服药的第一周，萨拉几乎没有感觉到任何变化。她开始有些怀疑——也许这不过是另一个希望落空的开始。但张医生告诉她，靶向药物不同于化疗，不会立刻引起剧烈的身体反应，真正的疗效需要时间来显现。他建议她做一次全面的血液检查，以观察体内癌细胞标志物的变化。

During the first week of medication, Sarah felt almost no change. She began to doubt—whether this was just another dashed hope. But Dr. Zhang told her that targeted drugs, unlike chemotherapy, don't cause immediate intense physical reactions; true efficacy requires time to manifest. He suggested she undergo a comprehensive blood test to monitor changes in cancer cell markers in her body.

两周后的检查结果令所有人眼前一亮：她体内的BCR-ABL融合基因拷贝数——这是费城染色体阳性ALL的关键致癌因子——比服药前下降了将近40%。张医生拿着报告单，难得地在嘴角露出一丝笑意：“陈女士，这个降幅相当可观。您的身体正在对药物产生响应。”

The test results two weeks later delighted everyone: the copy number of her BCR-ABL fusion gene—the key carcinogenic factor in Philadelphia chromosome-positive ALL—had dropped by nearly 40% compared to before she started taking the medication. Dr. Zhang held the report, rare smile at the corners of his mouth: "Ms. Chen, this reduction is quite significant. Your body is responding to the drug."

真正的转折发生在服药后的第六周。那天清晨，萨拉像往常一样在护士的陪同下去做例行检查。实验室的技术员在显微镜下观察她的血样时，突然愣住了——她放下显微镜，揉了揉眼睛，又重新凑上去看。然后她转过头，眼睛里闪烁着难以置信的光芒：“这不可能……这些是……正常淋巴细胞！”

The real turning point came in the sixth week after starting the medication. That morning, Sarah went for her routine checkup as usual, accompanied by a nurse. When the lab technician examined her blood sample under the microscope, she suddenly froze—she lowered the microscope, rubbed her eyes, then peered in again. Then she turned, her eyes sparkling with disbelief: "This is impossible... These are... normal lymphocytes!"

随后的全面检查证实了这个难以置信的结果：萨拉体内的癌细胞负荷已经降至检测不到的水平，骨髓穿刺结果显示造血功能正在恢复正常，她体内那套被癌症彻底破坏的免疫系统，正在靶向药物的帮助下一点一点重建。更令人惊喜的是，由于靶向药物具有高度特异性，它对正常细胞的伤害远小于传统化疗，萨拉在治疗期间几乎没有出现那种让化疗病人痛不欲生的恶心、呕吐和脱发反应。

The subsequent comprehensive examination confirmed this incredible result: Sarah's cancer burden had dropped to undetectable levels, bone marrow biopsy showed hematopoietic function gradually returning to normal, and her immune system—thoroughly devastated by cancer—was being rebuilt bit by bit with the help of targeted therapy. Even more exciting, because targeted drugs have high specificity, their damage to normal cells was far less than traditional chemotherapy. Sarah experienced almost none of the excruciating nausea, vomiting, and hair loss that torment chemotherapy patients.

六个月后，萨拉正式出院了。那天，波士顿的天空格外湛蓝，秋日的阳光温暖而柔和。她穿着一身素净的连衣裙——这是她确诊以来第一次能够穿上除了病号服以外的衣服——走出医院大门时，两个孩子正在门口等着她。内森像一颗小炮弹一样冲过来抱住她的腿，而艾米丽则矜持地站在一旁，但眼眶已经红了。

Six months later, Sarah was discharged from the hospital. That day, Boston's sky was especially blue, the autumn sun warm and gentle. She wore a plain dress—her first clothing other than a hospital gown since her diagnosis—and when she walked out of the hospital's main entrance, her two children were waiting for her. Nathan rushed over like a small cannonball and hugged her legs, while Emily stood aside with restraint, her eyes already reddened.

“妈妈，”艾米丽仰起头，认真地说，“你以后还会生病吗？”

"Mommy," Emily looked up, seriously asking, "will you be sick again?"

萨拉蹲下身，轻轻抚摸着女儿金色的长发：“妈妈现在好了。医生给妈妈吃的药，就像一支超级精准的特种部队，专门对付那些坏细胞。它们会把身体里的坏细胞全部消灭干净，然后妈妈就可以一直陪着你们长大了。”

Sarah knelt down, gently stroking her daughter's golden hair: "Mommy's all better now. The medicine the doctors gave me is like a super-precise special forces unit, specifically fighting those bad cells. The